Increased Infection Risk in Addison’s Disease and Congenital Adrenal Hyperplasia
Open accessPublished version of a preprint
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Context: Mortality and infection-related hospital admissions are increased in patients with primary adrenal insufficiency (PAI). However, the risk of primary care–managed infections in patients with PAI is unknown. Objective: To estimate infection risk in PAI due to Addison’s disease (AD) and congenital adrenal hyperplasia (CAH) in a primary care setting. Design: Retrospective cohort study using UK data collected from 1995 to 2018. Main outcome measures: Incidence of lower respiratory tract infections (LRTIs), urinary tract infections (UTIs), gastrointestinal infections (GIIs), and prescription counts of antimicrobials in adult PAI patients compared to unexposed controls. Results: A diagnosis of PAI was established in 1580 AD patients (mean age 51.7 years) and 602 CAH patients (mean age 35.4 years). All AD patients and 42% of CAH patients were prescribed glucocorticoids, most frequently hydrocortisone in AD (82%) and prednisolone in CAH (50%). AD and CAH patients exposed to glucocorticoids, but not CAH patients without glucocorticoid treatment, had a significantly increased risk of LRTIs (adjusted incidence rate ratio AD 2.11 [95% confidence interval (CI) 1.64–2.69], CAH 3.23 [95% CI 1.21–8.61]), UTIs (AD 1.51 [95% CI 1.29–1.77], CAH 2.20 [95% CI 1.43–3.34]), and GIIs (AD 3.80 [95% CI 2.99–4.84], CAH 1.93 [95% CI 1.06–3.52]). This was mirrored by increased prescription of antibiotics (AD 1.73 [95% CI 1.69–1.77], CAH 1.77 [95% CI 1.66–1.89]) and antifungals (AD 1.89 [95% CI 1.74–2.05], CAH 1.91 [95% CI 1.50–2.43]). Conclusions: There is an increased risk of infections and antimicrobial use in PAI in the primary care setting at least partially linked to glucocorticoid treatment. Future studies will need to address whether more physiological glucocorticoid replacement modes could reduce this risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Infectious illnesses can trigger an adrenal crisis and gastrointestinal and upper respiratory tract infections are the most common precipitants at all ages57,58,62,71.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [71]
Experimental — accuracy not yet measuredIn the citing paper
“Patients with adrenal insufficiency are at an increased risk of infection”
From ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency (2020) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Betterle, C., Dal Pra, C., Mantero, F., & Zanchetta, R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0466 · Cited by 758
(2013) · American Journal of Transplantation · doi:10.1111/ajt.12073 · Cited by 687
Blak, B., Thompson, M., Dattani, H., & Bourke, A. (2011) · Journal of Innovation in Health Informatics · doi:10.14236/jhi.v19i4.820 · Cited by 630
Lewis, J. D., Schinnar, R., Bilker, W. B., Wang, X., & Strom, B. L. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1335 · Cited by 602
Suppressive effects of androgens on the immune system
Trigunaite, A., Dimo, J., & Jørgensen, T. N. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.02.004 · Cited by 551
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506
Self-citationPremature Mortality in Patients with Addison’s Disease: A Population-Based Study
Bergthorsdottir, R., Leonsson-Zachrisson, M., Odén, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0076 · Cited by 490
Diagnosis and management of adrenal insufficiency
Bancos, I., Hahner, S., Tomlinson, J., & Arlt, W. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70142-1 · Cited by 467
Self-citationMaguire, A., Blak, B. T., & Thompson, M. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1688 · Cited by 301
Erichsen, M. M., Løvås, K., Fougner, K. J., Svartberg, J., Hauge, E. R., Bollerslev, J., Berg, J. P., Mella, B., & Husebye, E. S. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0550 · Cited by 240
Isidori, A. M., Venneri, M. A., Graziadio, C., Simeoli, C., Fiore, D., Hasenmajer, V., Sbardella, E., Gianfrilli, D., Pozza, C., Pasqualetti, P., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30398-4 · Cited by 211
Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Falhammar, H., Frisén, L., Norrby, C., Hirschberg, A. L., Almqvist, C., Nordenskjöld, A., & Nordenström, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2957 · Cited by 196
Fardet, L., Petersen, I., & Nazareth, I. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002024 · Cited by 168
Whitaker, M. J., Debono, M., Huatan, H., Merke, D. P., Arlt, W., & Ross, R. J. (2014) · Clinical Endocrinology · doi:10.1111/cen.12316 · Cited by 121
Self-citationBancos, I., Hazeldine, J., Chortis, V., Hampson, P., Taylor, A. E., Lord, J. M., & Arlt, W. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0969 · Cited by 110
Self-citationForss, M., Batcheller, G., Skrtic, S., & Johannsson, G. (2012) · BMC Endocrine Disorders · doi:10.1186/1472-6823-12-8 · Cited by 109
Crooks, C. J., West, J., & Card, T. R. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-007974 · Cited by 93
Ahmed, H., Farewell, D. M., Jones, H., Francis, N. A., Paranjothy, S., & Butler, C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190521 · Cited by 92
Gagliardi, L., Nenke, M. A., Thynne, T. R. J., von der Borch, J., Rankin, W. A., Henley, D. E., Sorbello, J., Inder, W. J., & Torpy, D. J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2433 · Cited by 85
Jenkins-Jones, S., Parviainen, L., Porter, J., Withe, M., Whitaker, M. J., Holden, S. E., Morgan, C. L., Currie, C. J., & Ross, R. J. M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0895 · Cited by 85
Hak, E., Rovers, M. M., Kuyvenhoven, M. M., Schellevis, F. G., & Verheij, T. J. M. (2006) · Family Practice · doi:10.1093/fampra/cmi121 · Cited by 78
Björnsdottir, S., Sundström, A., Ludvigsson, J. F., Blomqvist, P., Kämpe, O., & Bensing, S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3561 · Cited by 70
Smans, L. C. C. J., Souverein, P. C., Leufkens, H. G. M., Hoepelman, A. I. M., & Zelissen, P. M. J. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0879 · Cited by 70
Recent changes in the prevalence of diseases presenting for health care.
Fleming, D., Cross, K. W., & Barley, M. (2005) · Europe PMC (PubMed Central) · Cited by 64
Murray, R. D., Ekman, B., Uddin, S., Marelli, C., Quinkler, M., Zelissen, P. M. J., & the EU-AIR Investigators (2017) · Clinical Endocrinology · doi:10.1111/cen.13267 · Cited by 60
Mallappa, A., Nella, A. A., Sinaii, N., Rao, H., Gounden, V., Perritt, A. F., Kumar, P., Ling, A., Liu, C., Soldin, S. J., et al. (2018) · Clinical Endocrinology · doi:10.1111/cen.13813 · Cited by 45
Stoupa, A., González-Briceño, L., Pinto, G., Samara-Boustani, D., Thalassinos, C., Flechtner, I., Beltrand, J., Bidet, M., Simon, A., Piketty, M., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000369901 · Cited by 37
Iqbal, K., Halsby, K., Murray, R. D., Carroll, P., & Petermann, R. (2018) · Endocrine Connections · doi:10.1530/ec-18-0418 · Cited by 17
Imitating the cortisol profile improves the immune system
Müller, L., & Quinkler, M. O. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.5 · Cited by 16
Immunological pattern in patients with 21-hydroxylase deficiency
Parlato, F., Pisano, G., Brillante, M., Ferrone, R. F., Cavalcanti, M. R., Cosentini, E., Misiano, G., Brai, M., & Bellastella, A. (1994) · Journal of Endocrinological Investigation · doi:10.1007/bf03349677 · Cited by 1
Cited by
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citationHahner, S., Ross, R. J., Arlt, W., Bancos, I., Burger-Stritt, S., Torpy, D. J., Husebye, E. S., & Quinkler, M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00252-7 · Cited by 223
Self-citationManagement challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113
Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia
Merke, D. P., Mallappa, A., Arlt, W., Brac de la Perriere, A., Lindén Hirschberg, A., Juul, A., Newell-Price, J., Perry, C. G., Prete, A., Rees, D. A., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab051 · Cited by 109
Self-citationENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency
Arlt, W., Baldeweg, S. E., Pearce, S. H. S., & Simpson, H. L. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0361 · Cited by 107
Self-citation
Metadata
- Authors
- Tresoldi, A. S., Sumilo, D., Perrins, M., Toulis, K. A., Prete, A., Reddy, N., Wass, J. A. H., Arlt, W., & Nirantharakumar, K.
- Affiliations
- IRCCS Humanitas Research Hospital (IT)
- Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
- University of Birmingham (GB)
- Leicester Royal Infirmary (GB)
- Churchill Hospital (GB)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Corresponding author
- Arlt, Wiebke
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2019-09-18
- Volume
- 105
- Issue
- 2
- Pages
- 418-429
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC7046014
- OpenAlex
- W2973526830
- Cited by
- 65
- References
- 31
- Citations by year
- 2026: 7 · 2025: 3 · 2024: 6 · 2023: 11 · 2022: 12 · 2021: 18 · 2020: 8
- FWCI
- 7.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Funders
- Medical Research Council (0900567)
- UK Research and Innovation
- Health Data Research
- National Institute of Health Research
- Birmingham Biomedical Research Centre
- Department of Health and Social Care UK
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- Addison's disease, congenital adrenal hyperplasia, infection risk, lower respiratory tract infection, urinary tract infection, gastrointestinal infections, glucocorticoid therapy, cortisol, prednisolone, antimicrobial prescribing, antifungal prescribing, primary care, immunosuppression
- MeSH terms
- Addison Disease, Adrenal Hyperplasia, Congenital, Adult, Disease Susceptibility, Female, Glucocorticoids, United Kingdom, Humans, Infections, Male, Middle Aged, Primary Health Care, Retrospective Studies, Risk Factors, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.